SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $27.51 million. The enterprise value is -$8.13 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 41.97 million shares outstanding. The number of shares has increased by 2.31% in one year.
| Current Share Class | 41.97M |
| Shares Outstanding | 41.97M |
| Shares Change (YoY) | +2.31% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 2.17% |
| Owned by Institutions (%) | 14.79% |
| Float | 33.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.06 |
| Forward PS | 1.17 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.75, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.75 |
| Quick Ratio | 5.66 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.87 |
Financial Efficiency
Return on equity (ROE) is -53.29% and return on invested capital (ROIC) is -38.28%.
| Return on Equity (ROE) | -53.29% |
| Return on Assets (ROA) | -28.85% |
| Return on Invested Capital (ROIC) | -38.28% |
| Return on Capital Employed (ROCE) | -81.33% |
| Revenue Per Employee | $104,714 |
| Profits Per Employee | -$903,571 |
| Employee Count | 28 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SCYNEXIS has paid $23,000 in taxes.
| Income Tax | 23,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.38% in the last 52 weeks. The beta is 1.36, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | -48.38% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.84 |
| Relative Strength Index (RSI) | 45.96 |
| Average Volume (20 Days) | 563,398 |
Short Selling Information
The latest short interest is 1.23 million, so 2.94% of the outstanding shares have been sold short.
| Short Interest | 1.23M |
| Short Previous Month | 1.07M |
| Short % of Shares Out | 2.94% |
| Short % of Float | 3.73% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $2.93 million and -$25.30 million in losses. Loss per share was -$0.51.
| Revenue | 2.93M |
| Gross Profit | 2.93M |
| Operating Income | -34.65M |
| Pretax Income | -25.28M |
| Net Income | -25.30M |
| EBITDA | n/a |
| EBIT | -34.65M |
| Loss Per Share | -$0.51 |
Full Income Statement Balance Sheet
The company has $37.93 million in cash and $2.28 million in debt, giving a net cash position of $35.64 million or $0.85 per share.
| Cash & Cash Equivalents | 37.93M |
| Total Debt | 2.28M |
| Net Cash | 35.64M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | 36.43M |
| Book Value Per Share | 0.87 |
| Working Capital | 40.23M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -33.59M |
| Capital Expenditures | n/a |
| Free Cash Flow | -33.59M |
| FCF Per Share | -$0.80 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,181.72% |
| Pretax Margin | -862.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SCYNEXIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.31% |
| Shareholder Yield | -2.31% |
| Earnings Yield | -91.96% |
| FCF Yield | -122.09% |
Analyst Forecast
The average price target for SCYNEXIS is $3.00, which is 357.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 357.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 48.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 17, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 17, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
SCYNEXIS has an Altman Z-Score of -10.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.5 |
| Piotroski F-Score | 2 |